Laman UtamaRGEN • NASDAQ
add
Repligen Corp
$152.60
Selepas Waktu Dagangan:(0.00%)0.00
$152.60
Tutup: 17 Okt, 5:20:00 PTG GMT-4 · USD · NASDAQ · Penafian
Tutup sebelumnya
$154.55
Julat hari
$152.54 - $156.31
Julat tahun
$102.97 - $182.06
Permodalan pasaran
8.58B USD
Bilangan Purata
933.44K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Financial Post
1 hari lalu
This top TSX performer is up 190% this year. Can the gains keep rolling in?
1.21%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | 182.37J | 14.81% |
Perbelanjaan pengendalian | 83.38J | 10.29% |
Pendapatan bersih | 14.87J | 160.21% |
Margin untung bersih | 8.15 | 126.39% |
Pendapatan bagi setiap syer | 0.37 | 12.12% |
EBITDA | 29.70J | 26.73% |
Kadar cukai berkesan | 18.39% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 708.86J | -12.39% |
Jumlah aset | 2.90B | 1.24% |
Jumlah liabiliti | 839.89J | -4.73% |
Jumlah ekuiti | 2.06B | — |
Syer tertunggak | 56.26J | — |
Harga kepada buku | 4.22 | — |
Pulangan pada aset | 0.84% | — |
Pulangan pada modal | 0.89% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 14.87J | 160.21% |
Tunai daripada operasi | 28.61J | -32.19% |
Tunai daripada pelaburan | -7.84J | -5.93% |
Tunai daripada pembiayaan | -10.13J | -75.49% |
Perubahan bersih dalam tunai | 11.63J | -59.25% |
Aliran tunai bebas | -10.59J | -148.17% |
Perihal
Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biopharmaceutical drug developers and contract development and manufacturing organizations worldwide. Wikipedia
CEO
Diasaskan
1981
Ibu pejabat
Tapak web
Pekerja
1,778
